Ryan Randolph

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

Robert T. Jacobs, Bakela Nare, Stephen A. Wring et al. · PLoS neglected tropical diseases · 2011 · 299 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis

Bakela Nare, Stephen A. Wring, Cyrus J. Bacchi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 102 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis

Stephen A. Wring, Ryan Randolph, Seonghee Park et al. · Antimicrobial Agents and Chemotherapy · 2017 · 93 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Regulation of Human Immune Gene Expression as Influenced by a Commercial Blended Echinacea Product: Preliminary Studies

Ryan Randolph, Kevin W. Gellenbeck, K. Stonebrook et al. · Experimental Biology and Medicine · 2003 · 70 citations

Life Sciences, Immunology, Pharmacology +14

Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles

Katrien Van Bocxlaer, Eric Gaukel, Deirdre Hauser et al. · Antimicrobial Agents and Chemotherapy · 2018 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15